Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations were reorganized into a consolidated Locations section with multiple state entries. Per-state location headers were removed, the HHS Vulnerability Disclosure was deleted, and the page revision updated to v3.3.3.SummaryDifference0.9%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. No observable changes to study content or user-facing information in the screenshot.SummaryDifference0.0%

- Check41 days agoChange DetectedPubMed publications note updated to indicate that items are automatically filled from PubMed and may not all be about the study. Revision: v3.3.1 was added to the page.SummaryDifference0.1%

- Check48 days agoChange DetectedThe 'Notice Because of a lapse in government funding...' warning has been removed from the page. It previously stated that information might not be up to date and inquiries could be delayed.SummaryDifference0.2%

- Check63 days agoChange DetectedThe Study Details page remains the same, with identical sections and values across screenshots; only minor formatting/layout differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check93 days agoChange DetectedUpdate: the page version is updated from v3.0.2 to v3.2.0. No other content changes detected.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.